Drug Repurposing by Virtual Screening: Identification of New Already Approved ROCK Inhibitors as Promising Drugs to Target Neurodegeneration

Drug Repurposing by Virtual Screening: Identification of New Already Approved ROCK Inhibitors as Promising Drugs to Target Neurodegeneration

Saved in:

Bibliographic Details
Main Authors:	Lucas Silva Franco, Daniel Alencar Rodrigues, Gabriela Joras Baumart, Bárbara da Silva Mascarenhas de Jesus, Flávia Carvalho Alcantara Gomes, Lídia Moreira Lima, Carlos Alberto Manssour Fraga, Pedro de Sena Murteira Pinheiro
Format:	Article
Language:	English
Published:	American Chemical Society 2025-06-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c04340
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups
by: Gustavo Salgado Pires, et al.
Published: (2025-04-01)

Ebselen: A Promising Repurposing Drug to Treat Infections Caused by Multidrug-Resistant Microorganisms
by: Agostinho Alves de Lima e Silva, et al.
Published: (2024-01-01)

In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
by: Ridwan Abiodun Salaam, et al.
Published: (2025-03-01)

Computational drug repurposing in Parkinson’s disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates
by: Xin Guo, et al.
Published: (2025-04-01)

REPURPOSING DRUGS FOR CANCER THERAPY
by: Ege Arzuk, et al.
Published: (2022-08-01)

FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry
by: Manisha Singh, et al.
Published: (2025-03-01)

COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose–That Was the Question
by: Chris R. Triggle, et al.
Published: (2025-06-01)

Applications of Artificial Intelligence in Drug Repurposing
by: Zhaoman Wan, et al.
Published: (2025-04-01)

Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson’s disease model
by: Hye-Sun Lim, et al.
Published: (2025-05-01)

Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Drug repurposing in the treatment of chronic inflammatory diseases
by: Shivmuni Sarup, et al.
Published: (2024-11-01)

Drug repurposing: Clinical practices and regulatory pathways
by: K. Saranraj, et al.
Published: (2025-04-01)

A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma
by: Ioannis Ntafoulis, et al.
Published: (2024-12-01)

Repurposing FDA-approved drugs to find a novel inhibitor of alpha-ketoglutarate-dependent dioxygenase FTO to treat esophageal cancer
by: Zeinab Mohammadi, et al.
Published: (2025-05-01)

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation
by: Chawalit Ngernsombat, et al.
Published: (2024-12-01)

Repurposing the orphan drug nitisinone to control the transmission of African trypanosomiasis.
by: Marcos Sterkel, et al.
Published: (2021-01-01)

Repurposing of apoptotic inducer drugs against Mycobacterium tuberculosis
by: Kudakwashe Nyambo, et al.
Published: (2025-02-01)

Drug Repurposing to Inhibit Oncostatin M in Crohn’s Disease
by: Faranak Bahramimehr, et al.
Published: (2025-04-01)

Antimicrobial activities of Diltiazem Hydrochloride: drug repurposing approach
by: Omar K. Alduaij, et al.
Published: (2024-09-01)

Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery.
by: Mohammed Alrouji, et al.
Published: (2024-01-01)

Supplementa already published
by: L. Hoffman
Published: (2022-12-01)

Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
by: Saumya Choudhary, et al.
Published: (2025-07-01)

A promising drug repurposing approach for Alzheimer's treatment: Givinostat improves cognitive behavior and pathological features in APP/PS1 mice
by: Qi-Chao Gao, et al.
Published: (2024-12-01)

Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine
by: Douglas O. Ochora, et al.
Published: (2025-06-01)

A drug repurposing screen for whipworms informed by comparative genomics.
by: Avril Coghlan, et al.
Published: (2023-09-01)

Literature data-based de novo candidates for drug repurposing
by: Xianglong Liang, et al.
Published: (2025-08-01)

Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic
by: Manesh Manoj, et al.
Published: (2021-01-01)

Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health
by: Hyeon-Mi Kim, et al.
Published: (2025-02-01)

Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders
by: Ludovica Franceschin, et al.
Published: (2024-11-01)

Artificial Intelligence-Based Methods for Drug Repurposing and Development in Cancer
by: Sara Herráiz-Gil, et al.
Published: (2025-03-01)

In silico drug repurposing at the cytoplasmic surface of human aquaporin 1.
by: Aled R Lloyd, et al.
Published: (2025-01-01)

Editorial: Drug repurposing for cancer treatment: current and future directions
by: Marios Lampros, et al.
Published: (2025-02-01)

Drug repurposing: Bortezomib in the treatment of PTEN‐deficient iCCA
by: Shi‐jia Dai, et al.
Published: (2024-12-01)

Exploring the genomic and transcriptomic profiles of glycemic traits and drug repurposing
by: Min-Rou Lin, et al.
Published: (2025-05-01)

DTA Atlas: A massive-scale drug repurposing database
by: Madina Sultanova, et al.
Published: (2024-12-01)

The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension
by: Sila Ozlem Sener, et al.
Published: (2024-09-01)

Repurposing FDA-approved drugs and natural compounds to inhibit the RNA-dependent RNA polymerase domain of dengue virus 2 or dengue virus 3
by: Khadijeh Ahmadi, et al.
Published: (2025-04-01)

New to science and already disillusioned
by: Bruce Anderson
Published: (2009-03-01)

Novel Drug Combinations in Lung Cancer: New Potential Synergies Between 5-FU and Repurposed Drugs
by: Eduarda Ribeiro, et al.
Published: (2024-10-01)